Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023127 · ClinicalTrials.gov registry record · NA
Reducing Indoor Allergen Exposures in Northern Manhattan and the South Bronx
A NA study, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00023127: Completed NA study, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00023127 is a NA study that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00023127, a NA study, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Controlled trial of an intervention to reduce indoor exposures to cockroach allergens among asthmatic children in NYC.
Interventions
- PROCEDURE Integrated Pest Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Phase | NA |
What the finished NCT00023127 record still lists
NCT00023127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Integrated Pest Management is the first listed.
NCT00023127 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00023127 about?
NCT00023127 is a clinical study titled "Reducing Indoor Allergen Exposures in Northern Manhattan and the South Bronx". Controlled trial of an intervention to reduce indoor exposures to cockroach allergens among asthmatic children in NYC.
What is the current status of trial NCT00023127?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants.
What interventions are being tested in trial NCT00023127?
The interventions under investigation include: Integrated Pest Management (PROCEDURE).
Who is sponsoring clinical trial NCT00023127?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00023127's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models